Clindamycin controlled release

Drug Profile

Clindamycin controlled release

Alternative Names: C-Vad; Controlled-release clindamycin vaginal insert

Latest Information Update: 24 Jun 2015

Price : $50

At a glance

  • Originator Controlled Therapeutics (Scotland)
  • Class Antibacterials; Lincosamides; Small molecules
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Bacterial vaginosis

Most Recent Events

  • 28 May 2004 This controlled-release clindamycin vaginal insert is available for licensing (http://www.cytokinepharmasciences.com)
  • 28 May 2004 Phase-I clinical trials in Bacterial vaginosis in United Kingdom (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top